These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32267)

  • 1. Differences in antibacterial resistance related to differences in cell envelope structure of Pseudomonas aeruginosa and Pseudomonas cepacia [proceedings].
    Richards RM
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():14P. PubMed ID: 32267
    [No Abstract]   [Full Text] [Related]  

  • 2. Electron microscope study of the effect of benzalkonium, chlorhexidine and polymyxin on Pseudomonas cepacia.
    Richards RM; Cavill RH
    Microbios; 1981; 29(115):23-31. PubMed ID: 6265736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
    Klinger JD; Aronoff SC
    J Antimicrob Chemother; 1985 Jun; 15(6):679-84. PubMed ID: 3161856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas cepacia resistance to antibacterials.
    Richards RM; Richards JM
    J Pharm Sci; 1979 Nov; 68(11):1436-8. PubMed ID: 512895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    Isles A; Maclusky I; Corey M; Gold R; Prober C; Fleming P; Levison H
    J Pediatr; 1984 Feb; 104(2):206-10. PubMed ID: 6420530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between the antibacterial activity, sorptiveness and reversibility of the action of histones].
    Ashmarin IP; Zhdan-Pushkina SM; Pinevich AV
    Mikrobiologiia; 1970; 39(4):629-33. PubMed ID: 4992750
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
    Aronoff SC; Klinger JD
    J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing pattern of Pseudomonas aeruginosa resistance phenotype in a cancer hospital.
    Katrachoura A; Dimakopoulou M; Papavassiliou J; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):196. PubMed ID: 3151340
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of medium temperature and pH on the sensitivity of pathogenic pseudomonads to chemotherapeutic agents].
    Iliukhin VI; Batmanov VP
    Antibiot Khimioter; 1997; 42(4):21-3. PubMed ID: 9182502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructure of the cell envelope of Pseudomonas aeruginosa: electron microscopic and chemical observations.
    Eagon RG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S65-80. PubMed ID: 4213662
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance of bacteria of the genus Pseudomonas to hexavalent chromium compounds and the capacity for their reduction].
    Kvasnikov EI; Kliushnikova TM; Kasatkina TP; Kiprianova EA; Boĭko OI
    Mikrobiol Zh (1978); 1988; 50(6):24-7. PubMed ID: 3150515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
    Chiaradia V; Santini GF
    G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative sensitivity and resistance of some strains of Pseudomonas aeruginosa and Pseudomonas stutzeri to antibacterial agents.
    Russell AD; Mills AP
    J Clin Pathol; 1974 Jun; 27(6):463-6. PubMed ID: 4369876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Preliminary study of chloramphenicol resistance in Pseudomonas aeruginosa strains].
    Abdel-Sayed S; Piffaretti JC; Pitton JS
    Pathol Microbiol (Basel); 1975; 42(4):232-33. PubMed ID: 819891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug resistance of bacteria and countermeasures--current status of resistance. 3. Glucose-nonfermentative bacteria].
    Yabuuchi E
    Nihon Rinsho; 1986 Apr; 44(4):973-7. PubMed ID: 3093733
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
    Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
    Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility.
    Tattawasart U; Maillard JY; Furr JR; Russell AD
    J Hosp Infect; 1999 Jul; 42(3):219-29. PubMed ID: 10439995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.